UK's NICE Okays Crysvita For XLH In Kids After Partners Cut Price To NHS

Bow legs
XLH is an inherited genetic disorder leading to soft, weak bones and physical disabilities • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Drug Pricing

More from Scrip